(Updated - January 21, 2022 5:53 AM EST)

UBS analyst Eliana Merle initiates coverage on Moderna (NASDAQ: MRNA) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE